表紙
市場調査レポート

オピオイド誘発性便秘(OIC):世界の治験レビュー

Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 299745
出版日 ページ情報 英文 141 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
オピオイド誘発性便秘(OIC):世界の治験レビュー Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014
出版日: 2014年04月15日 ページ情報: 英文 141 Pages
概要

当レポートでは、オピオイド誘発性便秘(OIC)の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどを提供して、概略以下の構成でお届けいたします。

目次

イントロダクション

地域別の治験

  • 国別の治験動向
    • アジア太平洋地域の主要国
    • 欧州の主要国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験:腫瘍科の治験に対するオピオイド誘発性便秘の割合

G7諸国における治験:相別

G7諸国における治験:段階別

E7諸国における治験:腫瘍科の治験に対するオピオイド誘発性便秘の割合

E7諸国における治験:相別

E7諸国における治験:段階別

相別の治験

段階別の治験

評価項目別の治験

未完了の治験

一定期間に採用された被験者

スポンサータイプ別の治験

有望なスポンサー

  • オピオイド誘発性便秘の治療薬の治験に参加している主要企業

有望薬

最新の治験ニュース

治験プロファイル

  • 主要企業の治験概要
    • Salix Pharmaceuticals Ltd.
    • AstraZeneca PLC
    • Mundipharma International Limited
    • 塩野義製薬
    • Cubist Pharmaceuticals, Inc.
    • Theravance, Inc.
    • Pfizer Inc.
    • Novartis AG
    • Alkermes Plc
    • Alkermes Inc.(休止中)
  • 主要大学・研究機関・病院の治験概要
    • Friedrich-Schiller-Universitat Jena
    • The University of Vermont
    • St. John's Health System
    • VU University Medical Center
    • Shriners Hospitals for Children
    • Kuopio University Hospital
    • British Columbia Cancer Agency
    • UMC Utrecht Holding BV
    • Ullevaal University Hospital

主な臨床プロファイル

付録

図表

目次
Product Code: GDHC2092CTIDB

GlobalData's clinical trial report, "Opioid-Induced Constipation (OIC) Global Clinical Trials Review, H1, 2014" provides data on the Opioid-Induced Constipation (OIC) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Opioid-Induced Constipation (OIC). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Opioid-Induced Constipation (OIC). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Opioid-Induced Constipation (OIC)
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Opioid-Induced Constipation (OIC) to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Opioid-Induced Constipation (OIC)
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Opioid-Induced Constipation (OIC)
    • Oct 31, 2013: Synergy Pharmaceuticals Initiates Phase 2 Study of SP-333 in Patients with Opioid-Induced Constipation
    • Oct 14, 2013: AstraZeneca Announces New Safety Data For Naloxegol In Patients with Opioid-Induced Constipation
    • Oct 02, 2013: Synergy Pharmaceuticals Announces Plans to Initiate a Phase 2 Study of SP-333 for Opioid-Induced Constipation
    • Jul 18, 2013: Cubist Enrolls First Patient in Phase 3 Efficacy Studies Evaluating Bevenopran for the Treatment of Opioid-Induced Constipation
    • Feb 26, 2013: AstraZeneca Announces Results From Long-term Safety Trial Of Naloxegol In Patients With Opioid-induced Constipation
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Salix Pharmaceuticals Ltd.
      • Clinical Trial Overview of Salix Pharmaceuticals Ltd.
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Mundipharma International Limited
      • Clinical Trial Overview of Mundipharma International Limited
      • Shionogi & Co., Ltd.
      • Clinical Trial Overview of Shionogi & Co., Ltd.
      • Cubist Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cubist Pharmaceuticals, Inc.
      • Theravance, Inc.
      • Clinical Trial Overview of Theravance, Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Alkermes Plc
      • Clinical Trial Overview of Alkermes Plc
      • Alkermes Inc. (Inactive)
      • Clinical Trial Overview of Alkermes Inc. (Inactive)
    • Clinical Trial Overview of Top Institutes / Government
      • Friedrich-Schiller-Universitat Jena
      • Clinical Trial Overview of Friedrich-Schiller-Universitat Jena
      • The University of Vermont
      • Clinical Trial Overview of The University of Vermont
      • St. John's Health System
      • Clinical Trial Overview of St. John's Health System
      • VU University Medical Center
      • Clinical Trial Overview of VU University Medical Center
      • Shriners Hospitals for Children
      • Clinical Trial Overview of Shriners Hospitals for Children
      • Kuopio University Hospital
      • Clinical Trial Overview of Kuopio University Hospital
      • British Columbia Cancer Agency
      • Clinical Trial Overview of British Columbia Cancer Agency
      • UMC Utrecht Holding BV
      • Clinical Trial Overview of UMC Utrecht Holding BV
      • Ullevaal University Hospital
      • Clinical Trial Overview of Ullevaal University Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Region, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Opioid-Induced Constipation (OIC) to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Opioid-Induced Constipation (OIC) to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Opioid-Induced Constipation (OIC) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Salix Pharmaceuticals Ltd., 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mundipharma International Limited, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi & Co., Ltd., 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Cubist Pharmaceuticals, Inc., 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Theravance, Inc., 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alkermes Plc, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Alkermes Inc. (Inactive), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Friedrich-Schiller-Universitat Jena, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Vermont, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by St. John's Health System, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by British Columbia Cancer Agency, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials Market, Global, Clinical Trials by Ullevaal University Hospital, 2014*

List of Figures

  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Opioid-Induced Constipation (OIC) to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Opioid-Induced Constipation (OIC) to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Opioid-Induced Constipation (OIC) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Opioid-Induced Constipation (OIC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top